马艺文, 徐君南, & 孙涛. (2025). HR阳性HER2低表达晚期乳腺癌治疗研究 进展：2024 ASCO会议乳腺癌研究热点解读. Cancer Research on Prevention & Treatment, 52(2), 98. https://doi.org/10.3971/j.issn.1000-8578.2025.24.1033
Chicago Style (17th ed.) Citation马艺文, 徐君南, and 孙涛. "HR阳性HER2低表达晚期乳腺癌治疗研究 进展：2024 ASCO会议乳腺癌研究热点解读." Cancer Research on Prevention & Treatment 52, no. 2 (2025): 98. https://doi.org/10.3971/j.issn.1000-8578.2025.24.1033.
MLA (9th ed.) Citation马艺文, et al. "HR阳性HER2低表达晚期乳腺癌治疗研究 进展：2024 ASCO会议乳腺癌研究热点解读." Cancer Research on Prevention & Treatment, vol. 52, no. 2, 2025, p. 98, https://doi.org/10.3971/j.issn.1000-8578.2025.24.1033.
Warning: These citations may not always be 100% accurate.
